GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings has disclosed Non-Current Deferred Tax Liability across 3 years of filings, most recently posting $650000.0 for Q3 2022.

• Non-Current Deferred Tax Liability for Q3 2022 came in at $650000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $650000.0 (changed N/A YoY), and the FY2021 annual result was $244000.0, changed N/A from the prior year.
• Non-Current Deferred Tax Liability came in at $650000.0 for Q3 2022 at GoodRx Holdings, up from $455000.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q3 2020 to a low of $244000.0 in Q4 2021.
• The 3-year median for Non-Current Deferred Tax Liability is $455000.0 (2022), against an average of $703600.0.